Stock Analysis on Net
Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

Analysis of Revenues

Microsoft Excel

Revenues as Reported

Thermo Fisher Scientific Inc., income statement, revenues

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Consumables 17,587 17,597 20,624 22,608 18,527
Instruments 7,446 7,646 7,924 7,753 6,779
Services 17,846 17,614 16,367 8,850 6,912
Consolidated revenues 42,879 42,857 44,915 39,211 32,218

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Item Description The company
Consolidated revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Thermo Fisher Scientific Inc. consolidated revenues decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.